ASPIRE in-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Diabetes Science and Technology

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/193229681300700424PMID 23911183PMCID PMC3879766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypoglycaemia documented with real‐time continuous glucose sensing in a case of ‘dead in bed’ syndrome

  2013cited by this paper
• Analysis of Glucose Responses to Automated Insulin Suspension With Sensor-Augmented Pump Therapy

  2012cited by this paper
• Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE Study

  2012cited by this paper
• Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump

  2011cited by this paper
• Semi-Closed-Loop Insulin Delivery Systems: Early Experience with Low-Glucose Insulin Suspend Pumps

  2011cited by this paper
• Insulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia

  2011cited by this paper
• The ASPIRE Study: Design and Methods of an In-Clinic Crossover Trial on the Efficacy of Automatic Insulin Pump Suspension in Exercise-Induced Hypoglycemia

  2011cited by this paper
• Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy

  2011cited by this paper
• Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system.

  2010cited by this paper
• Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension

  2010cited by this paper
• Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension

  2009cited by this paper
• Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes.

  2005cited by this paper
• Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes*

  2002cited by this paper
• Mechanism of Awareness of Hypoglycemia: Perception of Neurogenic (Predominantly Cholinergic) Rather Than Neuroglycopenic Symptoms

  1993cited by this paper
• Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.

  1993cited by this paper

• Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases

  2023cites this paper
• Artificial pancreas in pediatrics

  2019cites this paper
• Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes

  2018cites this paper
• Optimisation du contrôle glycémique chez les patients diabétiques de type 1 par Mesure Continue du Glucose (MCG) et arrêt prédictif de la pompe : résultats de l’étude OMEGA

  2017influential citation
• [Proposals for therapeutic decisions according to glucose trends in patients with type 1 diabetes].

  2016cites this paper
• Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes.

  2016cites this paper
• The Future of Glucose Monitoring

  2016cites this paper
• Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications

  2015cites this paper
• Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study

  2015cites this paper
• Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery

  2015cites this paper
• Current Trends in Continuous Glucose Monitoring

  2014cites this paper